Fig. 4

Comprehensive analysis of the differences in immune cell infiltration between high- and low-risk patients in both the training and validation cohorts. A and B Heatmap of immune cells and immune functions between high-risk and low-risk patients in the training cohort (A) and the validation cohort (B). C and D) Comparison of immune cells based on the ssGSEA method between high-risk and low-risk patients in the training cohort (C) and the validation cohort (D). For each cell type, the left represents high-risk patients, and the right represents low-risk patients. The P value is shown at the top of the graph. E and F Comparison of immune functions based on the ssGSEA method between high-risk and low-risk patients in the training cohort (E) and the validation cohort (F)